Chemkart India share price, P/E, ROE & financials

As of 6 Nov 2026, Chemkart India trades at 13.3× trailing earnings, below the industry P/E of 18.2×, and the shares are 19% below their 52-week high. Sales and net profit grew 18% and 37% a year over 3 years, with ROCE of 21% and ROE of 24%. Debt is 0.14× equity. It is listed on an SME platform with a market cap of ₹278 Cr, ranked 47th of 76 Chemicals companies by market cap; the shares rose 12% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes.How we calculate this

past year

Open: ₹235.20
Day high: ₹235.20
Day low: ₹229.55
Prev. close: ₹241.60
Volume: 33K

Health check

5 good · 1 to check

ReturnsAhead
+11.8% over a year, better than 5 of 7 peers.
Price tagCheaper
P/E 13.3 vs industry 18.2.
GrowthStrong
Sales +17.8%, profit +36.9% a year over 3 years.
ProfitabilityStrong
ROCE 21.3% vs peer median 10.6%.
Balance sheetStretched
Debt 0.14× equity, interest covered 34.9×, Piotroski 3 of 9.
Red flagsNone found
No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Chemicals

75 listed peers. Screen the industry

Small cap

₹278 Cr, #47 of 76 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months: sales ₹319 Cr · profit ₹32 Cr

Market cap: ₹278 Cr; Small cap
P/E: 13.3; Industry 18.2
Price to book: 1.82; Peers 2.62
Dividend yield: 0.00%
ROE: 23.5%; Peers 11.7%
ROCE: 21.3%; Peers 10.6%
Debt to equity: 0.14; Debt ₹22 Cr
EPS (TTM): ₹17.26
OPM (TTM): 15.0%; Net margin 10.1%
Sales growth: +101.4%; Latest quarter vs a year ago
Profit growth: +96.3%; Latest quarter vs a year ago
Price to sales: 0.87; EV/EBITDA 6.0

Strengths

Return on equity of 23.5%.
Return on capital employed of 21.3%.
Quarterly profit up 96.3% on a year ago.
Quarterly sales up 101.4% on a year ago.
P/E of 13.3 against an industry P/E of 18.2.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Chemkart India

Chemkart India Limited engages in the trading of nutraceutical, health, and sports supplement ingredients in India. The company offers amino acids, health supplements, herbal extracts, nucleotides, proteins, and vitamin products. Chemkart India Limited was incorporated in 2020 and is based in Mumbai, India.

Headquarters: Mumbai
Employees: 30
Sector: Basic Materials
ISIN: INE0VWL01017
Website: chemkart.com

Price range

52 weeks

₹87.00₹282.00

Today

₹229.55₹235.20

Avg volume (3M): 20K
1-year return: plus 11.8%
From 52-week high: minus 18.6%

Peers · Chemicals

Capital-heavy industry columns

Compare with peers Screen the whole industry

Company
NAVINFLUORNavin Fluorine International	9,010.00	plus 1.87%	46,250	50.8	42.7	18.7%	34.3%	0.28	16.5%	plus 46.1%
DEEPAKNTRDeepak Nitrite	1,533.60	minus 0.67%	20,917	19.7	22.3	10.8%	18.0%	0.27	−0.5%	minus 11.9%
TATACHEMTata Chemicals	607.45	minus 1.36%	15,475	–	12.4	−3.0%	12.2%	0.36	−4.8%	minus 31.0%
DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp.	1,155.30	minus 0.69%	14,599	14.8	11.5	11.2%	17.6%	0.76	2.6%	minus 22.7%
RPELRaghav Productivity Enhancers	1,780.80	plus 0.95%	8,178	116.0	107.1	–	29.9%	0.02	23.5%	plus 95.4%
GNFCGujarat Narmada Valley Fertilizers and Chemicals	451.80	minus 1.87%	6,639	6.3	5.4	10.4%	14.8%	0.01	−8.8%	minus 7.2%
ACIArchean Chemical Industries	416.40	minus 1.95%	5,141	51.3	23.2	7.7%	20.0%	0.28	−9.2%	minus 34.6%
CHEMKARTChemkart India	229.55	minus 4.99%	278	13.3	8.7	21.3%	15.0%	0.14	17.8%	plus 11.8%
Median of 7 peers	–	−0.69%	14,599	35.2	22.3	10.6%	18.0%	0.28	−0.5%	−11.9%

Quarterly results

This company doesn’t report these figures in a format we can read yet.

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +17.8%
Profit CAGR 3Y: +36.9%
ROE: 23.5%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
131	132	203	215
–	+0.5%	+54.0%	+5.7%
120	111	170	187
11	20.9	32.9	28.2
8.4%	15.8%	16.2%	13.1%
0.1	0.5	1.8	0
0.3	1.1	1.5	0.8
0.3	0.4	0.7	0.5
10.5	20	32.5	26.9
27.2%	27.2%	24.5%	26.9%
7.7	14.5	24.5	19.7
–	+89.5%	+69.0%	minus 19.9%
6.33	12.00	20.28	–

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
1.4	1.4	9.5	12.1
13.1	27.7	43.8	118
11.3	12.5	17	5
11.7	12	16.1	22.4
37.5	53.5	86.4	157
5.5	5.3	8.8	13.9
–	–	0.2	5.6
0.1	0.1	2.8	37.5
31.8	48.1	74.6	100
37.5	53.5	86.4	157

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
0.1	−0	3.7	−2.7
−5.3	−0.2	−4.2	−4.9
5.3	0.2	3.3	43.4
0.1	−0.1	2.8	35.8
−5.3	−0.2	−4	−4.9
−5.2	−0.2	−0.3	−7.6

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you